‘Superpotent': Thyroid tablet recall upgraded to highest risk level by FDA

Source NBC Local
Original Load Date Sept. 25, 2026, 5:01 p.m.
Last Updated Sept. 25, 2026, 5:01 p.m.
Original URL https://www.nbcchicago.com/news/local/superpotent-thyroid-tablet-recall-upgraded-to-highest-risk-level-by-fda/3993840/

Article Preview

A recent nationwide thyroid medication recall has been upgraded by the Food and Drug Administration to the agency's highest risk level, with FDA officials warning the "superpotent" drug could "cause serious adverse health consequences or death." Drug company Vitruvias Therapeutics Inc. [ issued the...